CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, a PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
Medical Immunology (Russia) - Russian Federation
doi 10.15789/1563-0625-2017-2-165-174
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
SPb RAACI